ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AHI Allied Health

120.00
0.00 (0.00%)
08 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Allied Health LSE:AHI London Ordinary Share COM STK USD0.01
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 120.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Allied Healthcare International Inc Q3 Results

04/08/2009 12:00pm

UK Regulatory



 

TIDMAHI 
 
RNS Number : 8164W 
Allied Healthcare International Inc 
04 August 2009 
 

Revenues Increase 7.3%, at Constant Exchange Rates 
NEW YORK, NY--(Marketwire - August 04, 2009) - Allied Healthcare International 
Inc. (NASDAQ: AHCI) (AIM: AHI) 
Allied Healthcare International Inc. (NASDAQ: AHCI) (AIM: AHI) 
(http://www.alliedhealthcare.com), a leading provider of flexible healthcare 
staffing services in the United Kingdom, has issued financial results for its 
fiscal 2009 third quarter. 
To provide investors with an increased understanding of the Company's business, 
as in previous quarters, Allied is providing a breakdown of its revenues, gross 
profits, selling, general and administrative costs and operating income at 
constant exchange rates using the comparable prior period weighted average 
exchange rate. In addition, as the Company's revenues and gross profits are 
generated in the United Kingdom, an analysis is included, within the management 
discussion below, of the last seven quarters' revenues and gross profits in 
pounds sterling to enable investors to fully understand the underlying trends 
over these periods without the effects of currency exchange rates. As noted in 
the reported numbers, recent fluctuations in foreign exchange rates have 
significantly impacted the Company's current period results. 
Fiscal Third Quarter Results: 
For the third quarter of fiscal 2009, at constant exchange rates, revenues 
increased by $5.5 million, or 7.3%, to $80.5 million, compared with $75.0 
million reported during the same period in fiscal 2008. Contributing to the 
increase in revenues was Allied's Homecare revenues, which grew by 17.3% to 
$67.5 million. Nursing Home revenues declined by 25.3% to $7.3 million. Hospital 
revenues decreased by 26.0% to $5.7 million. After the unfavorable impact of 
currency exchange of $17.4 million, revenues decreased to $63.1 million. 
At constant exchange rates, total gross profit for the third fiscal quarter 
increased 5.8% to $24.5 million, compared with $23.1 million reported for the 
comparable quarter in fiscal 2008. Gross profit margin for the third quarter was 
30.4%, as compared to 30.8% for the comparable prior period. Foreign exchange 
decreased gross profit by $5.3 million to $19.2 million for the quarter. 
At constant exchange rates, SG&A for the third fiscal quarter was $20.5 million, 
compared with $19.4 million reported last year. As a percent of revenues, SG&A 
costs were 25.8%, compared to 25.9% in the comparable prior year period. Foreign 
exchange decreased costs by $4.2 million to $16.3 million for the quarter. 
At constant exchange rates, operating income for the third quarter of fiscal 
2009 increased to $4.0 million, compared to operating income of $3.7 million 
reported during the 2008 third fiscal quarter. Foreign exchange decreased 
operating income by $1.1 million to $2.9 million for the quarter. 
Net income for the third quarter of fiscal 2009 was $2.4 million, as compared 
with $2.5 million reported during the 2008 third fiscal quarter. Diluted 
earnings per share was $0.05 for the quarter, compared to diluted earnings per 
share of $0.05 last year. 
Fiscal Nine-Month Results: 
For the fiscal nine months ended June 30, 2009, at constant exchange rates, 
revenues increased by $12.8 million, or 5.7%, to $236.4 million, compared with 
$223.6 million reported during the same period in fiscal 2008. Contributing to 
the increase in revenues was Allied's Homecare revenues, which grew by 13.8% to 
$191.2 million. Nursing Home revenues declined by 21.1% to $25.3 million. 
Hospital revenues decreased by 15.2% to $19.9 million. After the unfavorable 
impact of currency exchange of $56.4 million, revenues decreased to $180.0 
million. 
At constant exchange rates, total gross profit for the fiscal nine months ended 
June 30, 2009, increased 7.4% to $72.5 million, compared with $67.5 million 
reported for the comparable period in fiscal 2008. Gross profit margin for the 
fiscal nine months ended June 30, 2009, increased to 30.6% from 30.2% for the 
comparable prior period. Foreign exchange decreased gross profit by $17.3 
million to $55.2 million for the quarter. 
At constant exchange rates, SG&A for the fiscal nine months ended June 30, 2009, 
was $60.0 million, compared with $59.1 million reported last year, an increase 
of 1.5%. As a percent of revenues, SG&A costs were 25.7% compared to 26.4% in 
the comparable prior year period. Foreign exchange decreased costs by $13.8 
million to $46.2 million for the quarter. 
At constant exchange rates, operating income for the fiscal nine months ended 
June 30, 2009, increased to $12.5 million, compared to operating income of $8.4 
million reported during the 2008 nine months ended June 30, an increase of 48.6% 
over the prior year. Foreign exchange decreased operating income by $3.5 million 
to $8.9 million for the nine-month period. 
Income from continuing operations for the nine months ended June 30, 2009, 
increased to $7.0 million, as compared with $5.9 million reported during the 
2008 fiscal nine-month period. Diluted earnings per share from continuing 
operations was $0.15 for the nine month period ended June 30, 2009, compared to 
diluted earnings per share from continuing operations of $0.13 last year. 
Net income for the nine months ended June 30, 2009, increased to $7.4 million, 
as compared with $5.9 million reported during the 2008 fiscal nine-month period. 
Diluted earnings per share was $0.16 for the nine-month period, which includes 
$0.01 from discontinued operations due to the release of reserves as a result of 
the warranty period within the sales agreement, related to the sale of the 
respiratory business in fiscal 2007, having expired. This compares to $0.13 for 
the same prior year period. 
At June 30, 2009, and September 30, 2008, Allied's cash balance was $33.7 
million (GBP20.4 million) and $26.2 million (GBP14.4 million), respectively, 
representing an underlying increase in the cash balance of GBP6.0 million. 
For the fiscal nine months ended June 30, 2009, depreciation and amortization 
was $2.8 million (GBP1.8 million) and capital expenditures were $2.2 million 
(GBP1.4 million). Days Sales Outstanding was twenty-four days at June 30, 2009 
(46 days including unbilled account receivables), and twenty-five days at June 
30, 2008 (44 days including unbilled account receivables). 
Management Discussion: 
"We continue to see good growth in our homecare business, which now represents 
almost 84% of our business," commented Sandy Young, Chief Executive Officer of 
Allied. "The revenue growth in the quarter of 17.3% was particularly pleasing 
and was ahead of the 10-15% growth range that we have recently been operating 
within. Our Continuing Care continues to grow strongly and accounts for over 15% 
of the revenues of this business. Continuing Care has benefitted from the 
restructuring we carried out earlier this year. We have low penetration in this 
market and our proposition of providing homecare with a lower level medical 
requirement via support staff under nurse supervision is popular with hospital 
trusts." 
Mr. Young continued: "Our nursing homes and hospital staffing business results 
continue to struggle but following our acceptance onto the new PASA framework 
agreements, which come into effect in October 2009, we are hopeful that the 
higher charges under this revised contract will give us opportunities going 
forward. The higher charges are necessary to enable us to effectively recruit 
staff to service this business. We currently have plans in the next financial 
year to re-launch this service line in a few of our regional offices as well as 
our existing London operation. 
"While current period SG&A running costs of 25.8% of revenues are lower than the 
prior year period, we are continuing to invest in certain areas of our business 
that includes such items as continuing care, learning disability, IT systems, 
and business improvement projects to ensure that we support future growth in 
revenues. At the same time, we maintain tight controls over other areas of SG&A 
costs so as to maintain our objective of reducing SG&A costs as a percent of 
revenues. 
"We currently have several business improvement initiatives under way with 
project management support. These projects cover winning new business, carer 
retention, bid implementation, and branch operations. There are also other 
projects supporting service delivery. We believe that being a high quality 
service provider is a key driver to increased revenue and profit growth. 
"The third quarter also concluded the successful pilot phase of our Coldharbour 
IT replacement. We now have thirteen branches successfully running on 
Coldharbour. The cost of the project is within the original budget and time 
projections with a total capital expenditure of $2.4 million and operating 
expense of $4.5 million. To date, expenditures have been $2.7 million split 
between $2.2 million capital and $0.5 million operating expense. The project 
will allow us to make further efficiencies in the way we process transactions 
and will also improve service delivery." 
Mr. Young concluded: "As noted in our previous quarter's press release, with 
nearly all our operations in the United Kingdom, we believe it is important for 
investors to see the underlying revenues and gross profits in pound currency as 
detailed below. This shows growth in our gross margins year to date of 7.4% and 
our third quarter gross margin of 30.4% is well within our expectations. Our 
SG&A costs year to date, excluding exchange effects, increased by 1.5%, compared 
to the prior year despite the increase in revenues that we have generated." 
Dr. Jeffrey Peris, Non-Executive Chairman of the Board of Allied, commented: 
"Sandy Young and the management team have achieved operating income for the 
first three quarters of $12.5 million, excluding exchange, which compares to 
$8.4 million for the same prior year's quarters. This is an increase of 48.6%, 
and reflects the continued improvements the Company is making across its 
business to help it affirm its position as one of the leaders in the U.K. 
homecare market place. We are pleased with the results of the third quarter and 
that the successes of previous quarters have enabled Allied to be included in 
the Russell 3,000 Index, thereby providing us with opportunities to reach 
additional investors." 
Conference Call Information -- August 4, 2009 at 10:00AM EST / 3:00PM GMT: 
Allied invites all those interested in listening to management's discussion of 
the results to join the call by dialing 877-407-0778 for domestic participants, 
and 201-689-8565 for international participants today, August 4, 2009, at 
10:00AM EST / 3:00PM GMT. Participants may also access a live webcast of the 
conference call through the "Investors" section of Allied Healthcare's Website: 
www.alliedhealthcare.com. A replay will be available for one week following the 
call by dialing 877-660-6853 for domestic participants, and 201-612-7415 for 
international participants. When prompted, please enter account number 286 and 
conference ID number 321299. The presentation will be available and archived on 
the Company's website for ninety days. 
In addition to disclosing results of operations that are determined in 
accordance with generally accepted accounting principles ("GAAP"), this press 
release also discloses non-GAAP results of operations that exclude or include 
certain charges. These non-GAAP measures adjust for foreign exchange effects. 
Management believes that the presentation of these non-GAAP measures provides 
useful information to investors regarding the Company's results of operations, 
as these non-GAAP measures allow investors to better evaluate ongoing business 
performance. Investors should consider non-GAAP measures in addition to, and not 
as a substitute for, financial measures prepared in accordance with GAAP. A 
reconciliation of the non-GAAP measures disclosed in this press release with the 
most comparable GAAP measures are included in the financial tables included in 
this press release. 
For more news and information on Allied Healthcare International Inc., please 
visit http://www.IRGnews.com/coi/AHCI where you can find the CEO's video, a fact 
sheet on the company, investor presentations, and more. 
ABOUT ALLIED HEALTHCARE INTERNATIONAL INC. 
Allied Healthcare International Inc. (http://www.alliedhealthcare.com) is a 
leading provider of flexible healthcare staffing services in the United Kingdom. 
Allied operates a community-based network of approximately one hundred ten 
branches with the capacity to provide carers (known as home health aides in the 
U.S.), nurses, and specialized medical personnel to locations covering 
approximately 90% of the U.K. population. Allied meets the needs of private 
patients, community care, nursing and care homes, and hospitals. 
FORWARD-LOOKING STATEMENTS 
Certain statements contained in this news release may be forward-looking 
statements. These forward-looking statements are based on current expectations 
and projections about future events. Actual results could differ materially from 
those discussed in, or implied by, these forward-looking statements. Factors 
that could cause actual results to differ from those implied by the 
forward-looking statements include: general economic and market conditions; 
Allied's ability to continue to recruit and retain flexible healthcare staff; 
Allied's ability to enter into contracts with local government social services 
departments, NHS Trusts, hospitals and other healthcare facility clients on 
terms attractive to Allied; the general level of patient occupancy at our 
clients' hospitals and healthcare facilities; dependence on the proper 
functioning of Allied's information systems; the effect of existing or future 
government regulation of the healthcare industry, and Allied's ability to comply 
with these regulations; the impact of medical malpractice and other claims 
asserted against Allied; the effect of regulatory change that may apply to 
Allied and that may increase costs and reduce revenues and profitability; 
Allied's ability to use net operating loss carry forwards to offset net income; 
the effect that fluctuations in foreign currency exchange rates may have on our 
dollar-denominated results of operations; and the impairment of goodwill, of 
which Allied has a substantial amount on the balance sheet, may have the effect 
of decreasing earnings or increasing losses. Other factors that could cause 
actual results to differ from those implied by the forward-looking statements in 
this press release include those described in Allied's most recently filed SEC 
documents, such as its most recent annual report on Form 10-K, all quarterly 
reports on Form 10-Q and any current reports on Form 8-K filed since the date of 
the last Form 10-K. Allied undertakes no obligation to publicly update or revise 
any forward-looking statements, whether as a result of new information, future 
events, or otherwise. 
 
 
 
 
 
 
Contacts: 
 
 
Allied Healthcare International Inc. 
Sandy Young 
Chief Executive Officer 
Paul Weston 
Chief Financial Officer 
UK 00-44-1785 810-600 
sandyyoung@alliedhealthcare.com 
paulweston@alliedhealthcare.com 
or 
The Investor Relations Group 
Adam Holdsworth 
212-825-3210 
or 
Cenkos Securities plc (Nominated Advisor) 
Elizabeth Bowman 
London: 00-44-20-7397-8928 
or 
Ian Soanes 
London: 00-44-20-7397-8924 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 QRTSSFSLLSUSEDA 
 

1 Year Allied Healthcare Chart

1 Year Allied Healthcare Chart

1 Month Allied Healthcare Chart

1 Month Allied Healthcare Chart

Your Recent History

Delayed Upgrade Clock